Harvard Wyss Institute, USA
Brain Targeting Program
Discovery of new transport shuttles for BBB transport and brain delivery. Transport of therapeutics (Abs, proteins, ASOs) and diagnostics into the brain. In vitro and in vivo BBB models. Pre-competitive industry sponsored research consortium for BBB delivery.
Existing collaborations relevant to drug delivery
https://wyss.harvard.edu/news/harvards-wyss-institute-initiates-industry-partnership-to-facilitate-brain-targeted-drug-delivery/ 2019-2022: Pre-competitive industry sponsored research with BMS/Celgene, Lundbeck, Eisai, FairJourney Biologics, and Cell Signaling Technology, to discover new BBB shuttles.
Publications relevant to drug delivery
Email for contact details